Literature DB >> 22087213

Concurrence of Multifocal Motor Neuropathy and Hashimoto's Thyroiditis.

Suk-Won Ahn1, Su-Hyun Kim, Byung-Su Park, Jeong-In Cha, Sung-Min Kim, Jung-Joon Sung, Kwang-Woo Lee.   

Abstract

BACKGROUND: Multifocal motor neuropathy (MMN) is an immune-mediated disorder that is characterized by slowly progressive and asymmetrical weakness, but its pathophysiological mechanism is uncertain. The hypothesis that MMN is an immunological disease has been supported by the proven therapeutic effects of intravenous immunoglobulin and the detection of antiganglioside antibodies in MMN patients. The coexistence of MMN with other immune diseases has been rarely reported. CASE REPORT: A 37-year-old woman visited our hospital complaining of weakness in both hands. The clinical manifestations coincided well with MMN: predominantly distal upper-limb weakness, asymmetric involvement, a progressive course, absence of sensory symptoms, absence of pyramidal signs, and sparing of the cranial muscles. The electrophysiological findings also supported a diagnosis of MMN, with motor nerve conduction block in the median, ulnar, and radial nerves, without sensory nerve involvement. The patient was simultaneously diagnosed as having Hashimoto's thyroiditis, which is a well-known immune-mediated disease.
CONCLUSIONS: The concurrence of MMN and Hashimoto's thyroiditis in our patient is significant for understanding the immunological characteristics of the two diseases.

Entities:  

Keywords:  MMN; hashimoto's thyroiditis; multifocal motor neuropathy

Year:  2011        PMID: 22087213      PMCID: PMC3212605          DOI: 10.3988/jcn.2011.7.3.168

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


  15 in total

1.  Hashimoto's disease and Dr. Hakaru Hashimoto.

Authors:  Nobuyuki Amino; Hisato Tada; Yoh Hidaka; Kazuo Hashimoto
Journal:  Endocr J       Date:  2002-08       Impact factor: 2.349

Review 2.  Multifocal motor neuropathy: current concepts and controversies.

Authors:  Eduardo Nobile-Orazio; Alberto Cappellari; Alberto Priori
Journal:  Muscle Nerve       Date:  2005-06       Impact factor: 3.217

3.  Acute conduction block in vitro following exposure to antiganglioside sera.

Authors:  K Arasaki; S Kusunoki; N Kudo; I Kanazawa
Journal:  Muscle Nerve       Date:  1993-06       Impact factor: 3.217

4.  A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.

Authors:  A Pestronk; D R Cornblath; A A Ilyas; H Baba; R H Quarles; J W Griffin; K Alderson; R N Adams
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

Review 5.  Multifocal motor neuropathy.

Authors:  E Nobile-Orazio
Journal:  J Neuroimmunol       Date:  2001-04-02       Impact factor: 3.478

Review 6.  The epidemiology of thyroid disease and implications for screening.

Authors:  C Wang; L M Crapo
Journal:  Endocrinol Metab Clin North Am       Date:  1997-03       Impact factor: 4.741

7.  Multifocal motor neuropathy: the diagnostic spectrum and response to treatment.

Authors:  Mark Slee; Arul Selvan; Michael Donaghy
Journal:  Neurology       Date:  2007-10-23       Impact factor: 9.910

8.  Antibodies to the ganglioside GD1b in a patient with motor neuron disease and thyroid adenoma.

Authors:  P S Fishman; M E Shy; D E Hart; P E Thompson; N R Cashman
Journal:  Arch Neurol       Date:  1991-11

Review 9.  Disease associations with autoimmune thyroid disease.

Authors:  Richard C Jenkins; Anthony P Weetman
Journal:  Thyroid       Date:  2002-11       Impact factor: 6.568

10.  Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association.

Authors:  Antonio Toscano; Carmelo Rodolico; Salvatore Benvenga; Paolo Girlanda; Matilde Laurà; Anna Mazzeo; Eduardo Nobile-Orazio; Francesco Trimarchi; Giuseppe Vita; Corrado Messina
Journal:  Neuromuscul Disord       Date:  2002-08       Impact factor: 4.296

View more
  3 in total

1.  Guillain-Barre syndrome and Hashimoto's thyroiditis.

Authors:  M Toudou Daouda; N S Obenda; L Maazou; D Camara; Z Souirti; A Elmidaoui; M F Belahsen
Journal:  QJM       Date:  2016-01-19

2.  The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.

Authors:  Lingxin Kong; Xiujuan Wu; Yanwei Cheng; Shan Liu; Kangding Liu; Chunrong Li
Journal:  Neurol Sci       Date:  2022-04-26       Impact factor: 3.830

3.  Guillain-Barré Syndrome developing in a patient with Graves' Disease.

Authors:  Anirban Majumder; Sagar Basu
Journal:  J ASEAN Fed Endocr Soc       Date:  2019-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.